Therapeutic antibodies to Marburg virus

US11440951B2 · kind B2 · utility

Assignee

• The Government of the United States, as represented by the Secretary of the Army · US

Inventors

• Philippe Thullier · Bernin, FR
• Jeffrey Froude, II · Frederick, US
• John M. Dye · Frederick, US

Key dates

• Filing date: Mar 9, 2018
• Grant date: Sep 13, 2022
• Expiry date: Oct 30, 2038

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2319/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Provided here are immunoglobulins and compositions containing one or more of said immunoglobulins reactive to a strain of Marburg virus. The immunoglobulins and compositions comprising said immunoglobulins can be used prophylactically to prevent a Marburg virus infection or to treat a patient that has been exposed to a Marburg virus in order to reduce a symptom.